| PERIOD ENDING | 30-Sep-09 | 30-Sep-08 | 30-Sep-07 | | Total Revenue | 44,434 | 48,967 | 47,304 | | Cost of Revenue | 28,990 | 33,944 | 33,929 | | | Gross Profit | 15,444 | 15,022 | 13,374 | | | Operating Expenses | | Research Development | 1,122 | 1,776 | 567 | | Selling General and Administrative | 13,714 | 16,119 | 19,751 | | Non Recurring | 15,091 | 9,300 | 5,220 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (15,133) | (12,174) | (12,163) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (467) | 221 | 194 | | Earnings Before Interest And Taxes | (14,950) | (11,953) | (11,969) | | Interest Expense | 380 | 386 | 1,011 | | Income Before Tax | (15,330) | (12,339) | (12,979) | | Income Tax Expense | 49 | (376) | 76 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,379) | (11,963) | (13,055) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (109) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,379) | (11,963) | (13,165) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,379) | ($11,963) | ($13,165) |
|
0.34% Nasdaq 0.00%
Income Statement
